240 related articles for article (PubMed ID: 22882381)
1. Reduction of allogeneic red blood cell usage during cardiac surgery by an integrated intra- and postoperative blood salvage strategy: results of a randomized comparison.
Weltert L; Nardella S; Rondinelli MB; Pierelli L; De Paulis R
Transfusion; 2013 Apr; 53(4):790-7. PubMed ID: 22882381
[TBL] [Abstract][Full Text] [Related]
2. Additional postoperative cell salvage of shed mediastinal blood in cardiac surgery does not reduce allogeneic blood transfusions: a cohort study.
Vermeijden WJ; Hagenaars JA; Scheeren TW; de Vries AJ
Perfusion; 2016 Jul; 31(5):384-90. PubMed ID: 26494485
[TBL] [Abstract][Full Text] [Related]
3. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl.
So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
Anesthesiology; 2014 Apr; 120(4):852-60. PubMed ID: 24434302
[TBL] [Abstract][Full Text] [Related]
4. Patient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients.
So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
Anesthesiology; 2014 Apr; 120(4):839-51. PubMed ID: 24424070
[TBL] [Abstract][Full Text] [Related]
5. [Post-operative retransfusion and intra-operative autotransfusion systems in total knee arthroplasty. A comparison of their efficacy].
Kučera B; Náhlík D; Hart R; Oceláková L
Acta Chir Orthop Traumatol Cech; 2012; 79(4):361-6. PubMed ID: 22980936
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of cell salvage in pediatric surgery.
Samnaliev M; Tran CM; Sloan SR; Gasior I; Lightdale JR; Brustowicz RM
Paediatr Anaesth; 2013 Nov; 23(11):1027-34. PubMed ID: 23952976
[TBL] [Abstract][Full Text] [Related]
7. The efficacy, safety and cost-effectiveness of intra-operative cell salvage in high-bleeding-risk cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial.
Xie Y; Shen S; Zhang J; Wang W; Zheng J
Int J Med Sci; 2015; 12(4):322-8. PubMed ID: 25897293
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent effects of intraoperative low volume red blood cell transfusions on postoperative outcomes in cardiac surgery patients.
Yu PJ; Cassiere HA; Dellis SL; Esposito RA; Kohn N; LaConti D; Hartman AR
J Cardiothorac Vasc Anesth; 2014 Dec; 28(6):1545-9. PubMed ID: 25263773
[TBL] [Abstract][Full Text] [Related]
9. Impact of intraoperative high-volume autologous blood collection on allogeneic transfusion during and after cardiac surgery: a propensity score matched analysis.
Henderson RA; Mazzeffi MA; Strauss ER; Williams B; Wipfli C; Dawood M; Taylor BS; Tanaka KA
Transfusion; 2019 Jun; 59(6):2023-2029. PubMed ID: 30882929
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative cell salvage is associated with reduced postoperative blood loss and transfusion requirements in cardiac surgery: a cohort study.
Vonk AB; Meesters MI; Garnier RP; Romijn JW; van Barneveld LJ; Heymans MW; Jansen EK; Boer C
Transfusion; 2013 Nov; 53(11):2782-9. PubMed ID: 23445352
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative cell salvage in infants undergoing elective cardiac surgery: a prospective trial.
Golab HD; Scohy TV; de Jong PL; Takkenberg JJ; Bogers AJ
Eur J Cardiothorac Surg; 2008 Aug; 34(2):354-9. PubMed ID: 18539043
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: the effects of the type of transfused red blood cell product and surgical setting.
Vamvakas EC
Transfus Med Rev; 2002 Oct; 16(4):304-14. PubMed ID: 12415516
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients.
Benjamin RJ; McCullough J; Mintz PD; Snyder E; Spotnitz WD; Rizzo RJ; Wages D; Lin JS; Wood L; Corash L; Conlan MG
Transfusion; 2005 Nov; 45(11):1739-49. PubMed ID: 16271099
[TBL] [Abstract][Full Text] [Related]
15. Impaired red blood cell deformability after transfusion of stored allogeneic blood but not autologous salvaged blood in cardiac surgery patients.
Salaria ON; Barodka VM; Hogue CW; Berkowitz DE; Ness PM; Wasey JO; Frank SM
Anesth Analg; 2014 Jun; 118(6):1179-87. PubMed ID: 24806142
[TBL] [Abstract][Full Text] [Related]
16. Effects of the Sangvia blood collection system on patients undergoing elective hip surgery.
Teetzmann R; Sørensen B; Liseth K; Opheim E; Hervig T
Transfus Apher Sci; 2014 Oct; 51(2):91-6. PubMed ID: 25151098
[TBL] [Abstract][Full Text] [Related]
17. The volume of returned red blood cells in a large blood salvage program: where does it all go?
Waters JH; Dyga RM; Waters JF; Yazer MH
Transfusion; 2011 Oct; 51(10):2126-32. PubMed ID: 21985047
[TBL] [Abstract][Full Text] [Related]
18. Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and cost-effectiveness.
Dietrich W; Thuermel K; Heyde S; Busley R; Berger K
J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):589-96. PubMed ID: 16202891
[TBL] [Abstract][Full Text] [Related]
19. A standardized multidisciplinary approach reduces the use of allogeneic blood products in patients undergoing cardiac surgery.
Van der Linden P; De Hert S; Daper A; Trenchant A; Jacobs D; De Boelpaepe C; Kimbimbi P; Defrance P; Simoens G
Can J Anaesth; 2001 Oct; 48(9):894-901. PubMed ID: 11606348
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
